Lv12
60 积分 2024-06-28 加入
Cancer statistics, 2024
2个月前
已完结
Real‐world effectiveness and safety of RC48‐ADC alone or in combination with PD‐1 inhibitors for patients with locally advanced or metastatic urothelial carcinoma: A multicenter, retrospective clinical study
6个月前
已完结
Study RC48-C014: Preliminary results of RC48-ADC combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma
6个月前
已关闭
皖公网安备34019202002308
